Lingering symptoms after treated Lyme disease are recognized: roughly 1 in 10 treated patients has months of fatigue, joint pain, or brain fog. Fishtown Medicine believes the symptoms first, reads Lyme testing at evidence grade, and does not treat with long-term antibiotics, because randomized trials found no durable benefit and the documented harms are serious.
TL;DR: Some people stay sick after Lyme disease is treated. That problem has a name, doctors study it, and it is not in your head. About 1 in 10 treated people has months of tiredness, pain, or foggy thinking. Careful studies gave people like this months of extra antibiotics, and the long courses did not cure them, and some people were badly hurt. So the plan is different: believe the symptoms, trust the tests that have been proven, and search for treatable causes like thyroid disease, low iron, sleep apnea, and a racing heart on standing. Write your story down with dates, gather your old records, and bring both to a doctor who will read them.
If Lyme disease is part of your story and your health never came back, you have probably collected 2 opposite verdicts by now. One doctor looked at a negative test and closed the case. Another looked at the same symptoms and offered months of antibiotics, along with a certainty the first doctor refused to give. Both visits left you carrying the illness alone. This page is the third conversation, the one you should have been offered first: the suffering is believed, the testing is read at evidence grade, and no treatment is prescribed without evidence to carry it.
Is post-treatment Lyme disease syndrome recognized?
Yes. Medicine has a name for staying sick after treated Lyme disease, a definition, and an active research program, and none of it depends on you proving anything beyond your own story.
The most careful measurement to date comes from Johns Hopkins, where researchers followed patients from the day their early Lyme disease was diagnosed and treated on time with a full 3-week course of doxycycline. Even in that best-case group, 13.7% went on to functionally limiting fatigue, pain, or cognitive symptoms, against 4.1% of comparable people without Lyme who were followed the same way. Across studies the estimates run from about 5 to 20 in 100 treated patients, depending on how strictly the syndrome is defined. However you count it, this is a large group of people, and their illness is documented territory.
The symptom list will sound familiar if you have read about long COVID and post-viral illness: deep fatigue, widespread pain, unrefreshing sleep, brain fog, and crashes that follow exertion, a kinship close enough that researchers now study these conditions side by side as infection-triggered chronic illnesses.
What causes it is still being worked out. The leading candidates are immune dysregulation that outlives the infection, autonomic nervous system dysfunction, and central sensitization, meaning a nervous system that keeps amplifying signals after the trigger is gone. Persistent infection after appropriate treatment has been searched for hard, and the weight of evidence says it is rare. Believing your symptoms does not require believing the bacteria are still there, and that distinction decides what treatment can safely promise you.
Why did 2 doctors tell you 2 opposite things?
Because your illness fell into a gap where tests stop settling the argument, and each doctor filled that gap with a different reflex.
On the acute side, there is no argument. The expanding rash called erythema migrans is diagnostic by itself in a region like ours, where the tick is established; no blood test is needed, and a standard antibiotic course, measured in days, treats it. The Delaware Valley has been Lyme country for decades, and the acute side of this illness, from tick bites through late-stage disease, is covered on the Lyme disease care page.
The argument starts after treatment, when symptoms stay and tests can no longer say why. A doctor with 12 minutes and a negative test tends to close the case, and you leave carrying symptoms with no name. A clinic organized around chronic Lyme reads the same picture the other way, often supported by tests no regulator has validated, and you leave carrying a diagnosis that explains everything and a treatment plan measured in months. One response dismisses the suffering while the other outruns the evidence, and neither one has read your whole story. The repair for both is the same: take the suffering as data, then grade every test and every treatment by what it can support.
What do Lyme tests measure well, and badly?
Lyme tests measure your immune system's memory of the bacteria, and everything they do well and badly follows from that one fact.
The validated approach is 2-tier serology: a first antibody test, confirmed by a second test when the first is positive or unclear. Late in an untreated infection, when the immune response has had months to build, the approach performs well, with sensitivity of 96 to 100% in late-stage disease. In the first weeks of infection it performs badly, catching only 30 to 40% of cases, because antibodies take weeks to develop. That is why the rash is treated without waiting for any test.
The traps run in the other direction too. Antibodies persist for years after the infection is cured, so a positive test long after treatment shows a memory, and it cannot show an active infection. IgM antibodies, the early-responder class, mislead in their own way: guidance is to set IgM results aside once an illness has run longer than about 30 days, because past that point false positives outnumber true ones. And cross-reactions from mononucleosis, autoimmune disease, and other infections can produce positive results with no Lyme behind them at all.
Then there are the tests that supply the certainty no standard laboratory can: urine antigen tests, unapproved culture methods, and in-house criteria that count antibody bands the validated criteria do not. The CDC and FDA cautioned against these directly, because their accuracy has never been established, and an unvalidated test cannot rule anything in. If you paid for one of those panels, you were doing something reasonable with the options you were given; you were searching for an answer after the standard system stopped searching with you. The results still cannot bear the weight of a months-long antibiotic plan, and a doctor who takes you seriously owes you that plain reading.
Do long-term antibiotics help?
No. This question has been tested in 5 randomized, placebo-controlled trials, and prolonged courses failed to produce durable benefit in every one of them.
The National Institutes of Health funded 4 of those trials in the United States. The first 2, published together in the New England Journal of Medicine in 2001, gave 129 patients with persistent symptoms 30 days of intravenous ceftriaxone followed by 60 days of oral doxycycline, or matching placebos: outcomes did not differ, whether or not the patients still carried Lyme antibodies. A 2003 trial gave 55 patients with severe post-Lyme fatigue 28 days of IV ceftriaxone; fatigue scores improved, thinking speed did not, and the authors concluded against the treatment, because the lone benefit appeared on the most placebo-responsive outcome while the therapy caused adverse events on the way. A 2008 trial went longer, 10 weeks of IV ceftriaxone for patients with objectively measured memory problems: cognition improved at week 12, the improvement was gone by week 24, and 26% of the antibiotic group had adverse events from the drug or the IV line, against 7% on placebo. A 2016 European trial then tested the oral version of the idea, 12 further weeks of doxycycline or a 2-drug alternative after 2 weeks of ceftriaxone in everyone: quality of life did not differ from placebo.
That is the benefit column: nothing durable, by mouth or by vein. The harm column is documented too. In 2017 the CDC published a case series of patients seriously harmed during treatment for a chronic Lyme diagnosis. A woman in her late 30s died of septic shock from a bloodstream infection seeded by the IV line placed for months of antibiotics. An adolescent developed septic shock from a line kept in place after 5 months of antibiotics had brought no improvement. Another patient's intensive antimicrobial courses ended in Clostridioides difficile colitis, a severe antibiotic-driven gut infection that ran for 2 years. Others in the series developed an infection of the spine and a deep abscess. Case reports carry less weight than trials, and they are in the record for a different purpose: they show what the risk side of this trade contains.
Get Real Answers
Tired of being told your labs are 'normal'? Dr. Ash digs deeper.
Dr. Ash has his own entry in that risk column. In his clinical work he has seen permanent deafness follow years of doxycycline prescribed as chronic Lyme treatment, hearing that never returned after the drug stopped. Nobody deserves to go through that, least of all for a therapy no trial supports. It is why every treatment conversation at Fishtown Medicine starts with the same 2 questions: what does the evidence say you stand to gain, and what do we know you could lose. For open-ended antibiotic courses in post-treatment Lyme, the trials answer the first question with nothing durable, and the answer to the second includes everything above. That arithmetic, and nothing about doubting you, is why the practice does not prescribe them.
None of this touches the defined multi-week courses used for documented late Lyme disease, such as Lyme arthritis or neurologic disease. Those have evidence behind them, clear endpoints, and an end date, and they are part of ordinary care here.
What should a workup look like instead?
It should read your whole story first, then test for the conditions that produce these same symptoms and can be treated, because finding even one of them raises your floor. At Fishtown Medicine the list usually includes:
- A full thyroid panel, with antibodies, because early autoimmune thyroid disease hides behind a normal screening test and wears fatigue and brain fog as its costume.
- Iron stores, meaning ferritin and iron studies, since iron deficiency causes exhaustion and cognitive symptoms years before anemia appears.
- A sleep evaluation, because unrefreshing sleep is core to this picture, and sleep apnea is common, underdiagnosed, and treatable.
- Heart rate and blood pressure, lying and then standing over 10 minutes. A sustained jump of 30 or more beats per minute with symptoms points to POTS, postural orthostatic tachycardia syndrome, an autonomic problem that can follow infections including Lyme. If your symptoms span several systems and you have started connecting dots on your own, that pattern has its own page.
- An assessment for post-exertional malaise, the delayed crash after doing too much. When it is present, the illness fits an ME/CFS pattern, and pacing comes before any exercise prescription.
- A look at burning, prickling, or electric pain, which standard nerve tests miss when the cause is small fiber neuropathy, a findable and sometimes treatable nerve problem.
- A mood screen, handled with respect. Depression arrives alongside long illness and deserves care of its own; a positive screen adds a diagnosis and takes nothing away from this one.
Tick-borne co-infections belong in this workup too, at evidence grade. The same tick can carry anaplasmosis, a bacterial infection found by PCR blood testing and treated with a defined course of doxycycline, and babesiosis, a malaria-like parasite of red blood cells confirmed on a blood smear or by PCR and treated with atovaquone plus azithromycin. Both exist in Pennsylvania, both are testable, and both are curable. A co-infection that can be confirmed can also be ruled out, and that separates these diagnoses from the open-ended kind, where a label rests on symptoms alone and no result can ever end the search.
The broader version of this investigation, for anyone whose main symptom is months of exhaustion, is laid out in the fatigue workup. And while the workup runs, symptoms are treated as symptoms: sleep protected, pain addressed, pacing taught when crashes follow exertion, because relief does not need to wait for the last result.
Guidance from the Clinic
How does Fishtown Medicine approach this?
With time, and in one set of hands. If you have told this story more times than you can count, the intake does not make you start over: write what you have the energy for, upload the records and lab reports you already hold, and once you connect, the practice can request the rest of your records for you, so the retelling stops. Dr. Ash reads all of it before the first conversation, which means the conversation begins where your story left off.
From there, the sequence is the one this page describes. Testing is interpreted at evidence grade, including anything a specialty laboratory reported along the way. The differential above is worked in an order set by your history, treatable findings are treated, and symptoms are managed while the picture comes into focus. When a piece needs a specialist, cardiology for autonomic confirmation or neurology for small fiber testing, the referral goes out with the groundwork already done, and every result comes back to Dr. Ash, who reads every one himself. Your case stays whole in one place instead of scattering across offices that never compare notes.
When do symptoms need attention now?
A short list of symptoms needs same-day care instead of a scheduled workup. Go to urgent care or an emergency department for a new facial droop, fainting, a heart that races or stumbles at rest, chest pain, shortness of breath, a severe headache with a stiff neck, new weakness or numbness on one side, a hot swollen joint with fever, or a spreading rash with fever. Unintentional weight loss, drenching night sweats, or fevers that keep returning also need prompt evaluation, because they point away from post-treatment Lyme and toward something that should be found quickly. Early disseminated Lyme disease can involve the heart and the nervous system, and those presentations do well when they are caught and treated without delay.
Key Takeaways
- Staying sick after treated Lyme disease is recognized: about 1 in 10
Related at Fishtown Medicine
- Lyme Disease Care in Philadelphia - the acute side: tick bites, rashes, testing, and treatment
- When You Never Got Better - the post-viral relative of this illness
- Tired for Months: The Fatigue Workup - the general version of this investigation
- Connected Your Own Dots: POTS, MCAS, and Hypermobility - when the pattern spans systems
- Small Fiber Neuropathy - the nerve problem standard tests miss
Scientific References
- Aucott JN, Yang T, Yoon I, Powell D, Geller SA, Rebman AW. "Risk of post-treatment Lyme disease in patients with ideally-treated early Lyme disease: A prospective cohort study." International Journal of Infectious Diseases. 2022;116:230-237. Journal
- Klempner MS, Hu LT, Evans J, et al. "Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease." New England Journal of Medicine. 2001;345(2):85-92. NEJM
- Krupp LB, Hyman LG, Grimson R, et al. "Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial." Neurology. 2003;60(12):1923-1930. Journal
- Fallon BA, Keilp JG, Corbera KM, et al. "A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy." Neurology. 2008;70(13):992-1003. Journal
- Berende A, ter Hofstede HJM, Vos FJ, et al. "Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease." New England Journal of Medicine. 2016;374(13):1209-1220. NEJM
- Marzec NS, Nelson C, Waldron PR, et al. "Serious Bacterial Infections Acquired During Treatment of Patients Given a Diagnosis of Chronic Lyme Disease - United States." MMWR Morbidity and Mortality Weekly Report. 2017;66(23):607-609. CDC
- Moore A, Nelson C, Molins C, Mead P, Schriefer M. "Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States." Emerging Infectious Diseases. 2016;22(7):1169-1177. CDC EID
- John TM, Taege AJ. "Appropriate laboratory testing in Lyme disease." Cleveland Clinic Journal of Medicine. 2019;86(11):751-759. Journal
- Centers for Disease Control and Prevention. "Notice to Readers: Caution Regarding Testing for Lyme Disease." MMWR. 2005;54(5):125. CDC
- Mead P, Petersen J, Hinckley A. "Updated CDC Recommendation for Serologic Diagnosis of Lyme Disease." MMWR. 2019;68(32):703. CDC
- Lantos PM, Rumbaugh J, Bockenstedt LK, et al. "Clinical Practice Guidelines by the IDSA, AAN, and ACR: 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease." Clinical Infectious Diseases. 2021;72(1):e1-e48. Oxford / IDSA
- Infectious Diseases Society of America. "IDSA 2020 Guideline on Diagnosis and Management of Babesiosis." IDSA
Frequently Asked Questions
Common Questions
Deep-Dive Questions
Ready when you are
The chat is our AI assistant, answering from our published guides. To talk it through with Dr. Ash himself, start with the intake.
